Trial Profile
The Impact Of Nicotinic acid (Niacin) And Laropiprant (LRPT) On Increased Triglyceride more than 300 And its implications with low High Density Lipoprotein Cholesterol (males less than 40 females less than 45)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Niacin/laropiprant (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms PURSE HIS
- 04 Nov 2011 New trial record